What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Typhoid Fever

First-Line Treatment Recommendation

Azithromycin 500 mg once daily for 7 days is the recommended first-line treatment for typhoid fever, particularly for cases originating from South or Southeast Asia where fluoroquinolone resistance exceeds 70%. 1, 2

Treatment Algorithm Based on Clinical Severity and Geographic Origin

Severe Cases (Sepsis, Encephalopathy, or Septic Shock)

  • Start IV ceftriaxone 2g daily immediately after obtaining blood, stool, and urine cultures 2, 3
  • Continue for 14 days total to minimize relapse risk (relapse rate <8%) 2, 3
  • Transition to oral therapy when clinically improved 1
  • Consider adding corticosteroids in severe typhoid fever 2

Uncomplicated Cases from South/Southeast Asia (High Fluoroquinolone Resistance)

  • Azithromycin 500 mg once daily for 7-14 days is preferred 1, 2
  • Azithromycin demonstrates superior efficacy with lower clinical failure (OR 0.48) and dramatically lower relapse rates (OR 0.09) compared to ceftriaxone 1
  • Alternative: Oral cefixime or IV ceftriaxone if azithromycin unavailable 1, 2

Uncomplicated Cases from Other Regions (If Susceptibility Confirmed)

  • Fluoroquinolones (ciprofloxacin 500 mg twice daily or ofloxacin) for 7 days if organism is susceptible to both ciprofloxacin AND nalidixic acid on disc testing 1, 3, 4
  • Critical caveat: Ciprofloxacin disc testing alone is unreliable; the organism must also be sensitive to nalidixic acid to be considered truly fluoroquinolone-sensitive 3
  • Fever clearance typically occurs within 4 days with cure rates >96% 2
  • Alternative older agents (if fully susceptible): chloramphenicol, amoxicillin, or trimethoprim-sulfamethoxazole 1

Pediatric Considerations

  • Children <3 months: Use third-generation cephalosporin 2
  • Children 1-17 years: Azithromycin or ceftriaxone based on severity and resistance patterns 2
  • Note that fluoroquinolones carry increased risk of joint-related adverse events in pediatric populations 4

Treatment Duration and Monitoring

  • Continue treatment for 14 days regardless of agent chosen to reduce relapse risk 2, 3
  • Expected fever clearance: 4-5 days with appropriate therapy 1, 2
  • Monitor for complications (intestinal perforation, GI bleeding, encephalopathy) which occur in 10-15% of patients, particularly if illness duration exceeds 2 weeks 2, 3
  • Common adverse effects of azithromycin include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1

Critical Pitfalls to Avoid

  • Never use ciprofloxacin empirically for cases originating from South Asia due to resistance rates exceeding 70% 1, 3, 5
  • Do not rely on ciprofloxacin disc testing alone; verify nalidixic acid susceptibility 3
  • Avoid shorter treatment courses (<14 days) as this increases relapse risk 2, 3
  • Previous typhoid vaccination provides incomplete protection and does not protect against paratyphoid fever 1, 3
  • Extensively drug-resistant strains have emerged in Pakistan, requiring careful consideration of local resistance patterns 5, 6

Diagnostic Confirmation

  • Blood culture remains the gold standard (sensitivity 40-80% in first week) with 2-3 specimens of 20 mL each in adults drawn prior to antibiotics 2
  • Bone marrow culture is more sensitive, especially if antibiotics already administered 2
  • Larger blood volumes are needed due to low bacteremia (0.3 CFU/mL) 2

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Typhoid Fever Diagnostic and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Typhoid Fever Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.